Tetra Radar · FDA Approvals · Decision date

MK-6240: FDA decision date

Lantheus Holdings Inc (LNTH) · 13 August 2026

In October 2025, we announced that the FDA had accepted our NDA for MK-6240, our registrational F-18 tau-targeted PET imaging agent for the detection of tau neurofibrillary tangle pathology in patients with cognitive impairment being evaluated for Alzheimer’s disease, and has set a PDUFA target action date of August 13, 2026.

Source: 10-Q of 6 August 2026

The FDA approved it on 13 August 2026.

The FDA approved Tauklarify to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify patients with tau neurofibrillary tangle pathology.

Lantheus Holdings Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.